AE Management with CDK4/6 Inhibitors: Strategies for Treatment Continuity and Optimal Patient Outcomes

Medical professionals discuss proactive symptom management for adverse events like diarrhea, hair thinning, cytopenia, and neutropenia, offering guidance on dose reduction and treatment holds to optimize patient outcomes while minimizing adverse effects.

Related Keywords

, Optimizing Patient Outcomes , Stage Breast Cancer , Treatment Continuity , Optimal Patient Outcomes , Dose Reductions , Diarrhea , Tolerance , Imodium , Toxicity , Loperamide , Cytopenia , Hair Thinning , Neutropenia ,